Inhibition of angiotensin converting enzyme induces mechanical allodynia through increasing substance P expression in mice

Neurochem Int. 2021 Jun:146:105020. doi: 10.1016/j.neuint.2021.105020. Epub 2021 Mar 17.

Abstract

Although emerging evidence shows that angiotensin converting enzyme (ACE) is associated with pain, it is not clear whether inhibition of ACE could affect to nociceptive transmission and which mediators are involved in this process. Here we investigated whether administration of the ACE inhibitors, captopril and enalapril increases the expression of substance P (SP) and whether this increase contributes to the induction of mechanical allodynia in mice. ACE was expressed in the lumbar dorsal root ganglion (DRG) and the superficial dorsal horn (SDH) region of the spinal cord in mice. Either intraperitoneal or intrathecal administration of the ACE inhibitors, captopril and enalapril for 10 days significantly increased the paw withdrawal frequency to innocuous mechanical stimuli and the levels of SP in both the lumbar DRG and the SDH region of the spinal cord dorsal horn. In addition, intraperitoneal administration of the SP receptor (neurokinin-1 receptor) antagonist, L-733,060 suppressed mechanical allodynia that was induced by pretreatment of captopril and enalapril. Intraplantar administration of SP for 3 days induces mechanical allodynia, and this effect was reduced by exogenous ACE administration. These findings demonstrate that inhibition of ACE increases the levels of SP in both the lumbar DRG and spinal cord dorsal horn, ultimately contributing to the induction of mechanical allodynia in mice.

Keywords: Angiotensin converting enzyme; Mechanical allodynia; Neurokinin-1 receptor; Pain; Substance P.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / administration & dosage
  • Angiotensin-Converting Enzyme Inhibitors / toxicity*
  • Animals
  • Ganglia, Spinal / drug effects
  • Ganglia, Spinal / metabolism
  • Gene Expression
  • Hyperalgesia / chemically induced*
  • Hyperalgesia / metabolism*
  • Injections, Intraperitoneal
  • Injections, Spinal
  • Male
  • Mice
  • Mice, Inbred ICR
  • Peptidyl-Dipeptidase A / metabolism*
  • Spinal Cord Dorsal Horn / drug effects
  • Spinal Cord Dorsal Horn / metabolism
  • Substance P / biosynthesis*
  • Substance P / genetics

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Substance P
  • Peptidyl-Dipeptidase A